1. A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides. (16th December 2020) Authors: Peric, Mihaela; Pešić, Dijana; Alihodžić, Sulejman; Fajdetić, Andrea; Herreros, Esperanza; Gamo, Francisco Javier; Angulo‐Barturen, Iñigo; Jiménez‐Díaz, María Belén; Ferrer‐Bazaga, Santiago; Martínez, María S.; Gargallo‐Viola, Domingo; Mathis, Amanda; Kessler, Albane; Banjanac, Mihailo; Padovan, ... Journal: British journal of pharmacology Issue: Volume 178:Number 2(2021) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects. Issue 6 (20th October 2014) Authors: Wilfret, David A.; Walker, Jill; Voitenleitner, Christian; Baptiste‐Brown, Sharon; Lovern, Mark; Kim, Joseph; Adkison, Kimberly; Shotwell, Brad; Mathis, Amanda; Moss, Lee; Lee, Daniel; Yu, Lou; Gan, Jianjun; Spaltenstein, Andrew Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 6(2014:Nov./Dec.) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys. (4th October 2017) Authors: Warren, Travis; MacLennan, Steve; Mathis, Amanda; Giuliano, Enzo; Taylor, Ray; Sheridan, William Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus. (4th October 2017) Authors: Lim, So-Yon; Osuna, Christa; Lakritz, Jessica; Chen, Elsa; Yoon, Gyeol; Taylor, Ray; MacLennan, Steve; Leonard, Michael; Giuliano, Enzo; Mathis, Amanda; Berger, Elliot; Babu, Ys; Sheridan, William; Whitney, James Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects. Issue 4 (19th February 2022) Authors: Mathis, Amanda; Collins, David; Dobo, Sylvia; Walling, Dennis M.; Sheridan, William P.; Taylor, Ray Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 4(2022) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema. Issue 4 (25th February 2022) Authors: Mathis, Amanda; Sale, Mark; Cornpropst, Melanie; Sheridan, William P.; Ma, Shu Chin Journal: Clinical and translational science Issue: Volume 15:Issue 4(2022) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza. (4th October 2017) Authors: Vanchiere, John; Plunkett, Stephanie; Annamalai, Rajasekaran; Julien, Katie; Peterson, James; Goisse, Marcy; Christensen, Shane; Mehta, Priyesh; Coleman, Stephen; Munoz, Flor; Flynt, Amy; Dobo, Sylvia; Nagy, Eniko; Kargl, Deborah; Mathis, Amanda; Collis, Phil; Sheridan, William Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗